American Academy of Pediatrics (AAP)
FDANonrulemakingFDA-2024-N-4392

Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants; Public Workshop; Request for Comments

RIN
Last modified
Nov 27, 2024
Comment window
closed 610d ago
American Academy of Pediatrics (AAP) filings
2

Activity

American Academy of Pediatrics (AAP) filed 2 comments on this docket between Nov 1, 2024 and Nov 27, 2024. 2 other organizations filed here. The comment window closed 610d ago.

What American Academy of Pediatrics (AAP) filed (2)

Nov 27, 2024· Comment from New York Chapter 2 of the American Academy of Pediatrics· FDA-2024-N-4392-0006

Filed on regulations.gov — full text not in the inline record.

Nov 1, 2024· Comment from American Academy of Pediatrics· FDA-2024-N-4392-0004

Statement on behalf of American Academy of Pediatrics from Section on Neonatal-Perinatal Medicine

Abstract

No abstract recorded.

View on regulations.gov →
Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants; Public Workshop; Request for Comments (FDA) — American Academy of Pediatrics (AAP) | OpenPolis